Stifel Maintains Black Diamond Therapeutics(BDTX.US) With Buy Rating, Cuts Target Price to $16

Futu NewsNov 6 21:37 · Ratings

Express News | Black Diamond Therapeutics Inc : Stifel Cuts Target Price to $16 From $18

BreakingsNov 6 20:03

Strong Buy Rating for Black Diamond Therapeutics Driven by Financial Stability and Promising Clinical Developments

TipRanksNov 5 23:25 · Ratings

Express News | Black Diamond Therapeutics Inc: Clinical Updates of Bdtx-1535 in Egfrm Nsclc and Regulatory Feedback Expected in Q1 2025

BreakingsNov 5 21:02

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswireNov 5 21:00

Black Diamond Theraptcs Cash, Cash Equivalents, and Investments of $112.7 M as of Sept 30 >BDTX

Dow JonesNov 5 21:00